Abstract | PURPOSE: The effects of intravitreal triamcinolone acetonide on macular oedema have been evaluated in many studies. Good short-time effects are usually reported on visual function and macular oedema. However, adverse events like intraocular hypertension and cataract formation have been described in humans, and retinal toxicity is found in experimental studies. CASE REPORT: RESULTS: The macular oedema disappeared after each intravitreal injection, but each time it recidivated some months later. Visual acuity improved only after the first injections. After six intravitreal injections, visual acuity was limited to counting fingers in the absence of macular oedema. OCT and ERG results show central and peripheral retinal damage that could be a consequence of a retinotoxic property of triamcinolone acetonide. CONCLUSION:
|
Authors | Claudia Schulze-Döbold, Michel Weber |
Journal | International ophthalmology
(Int Ophthalmol)
Vol. 29
Issue 5
Pg. 427-9
(Oct 2009)
ISSN: 1573-2630 [Electronic] Netherlands |
PMID | 18618083
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Glucocorticoids
- Triamcinolone Acetonide
|
Topics |
- Electroretinography
- Glucocorticoids
(administration & dosage, adverse effects)
- Humans
- Injections, Intraocular
- Macular Edema
(diagnosis, drug therapy, etiology)
- Male
- Middle Aged
- Tomography, Optical Coherence
- Triamcinolone Acetonide
(administration & dosage, adverse effects)
- Uveitis
(complications)
- Vision Disorders
(chemically induced)
- Vitreous Body
|